Trials / Terminated
TerminatedNCT04494035
AVATR - Arteriovenous Access Thrombosis Removal With CAPERE Thrombectomy System
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Medtronic Endovascular · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, single-arm, non-blinded study, intending to treat and collect and evaluate data in up to ten (10) human subjects who are currently being treated with hemodialysis and who present with acute thrombosis in their arteriovenous (AV) grafts, treated with the CAPERE® Thrombectomy System.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CAPERE Thrombectomy System | Arteriovenous graft thrombectomy |
Timeline
- Start date
- 2020-01-14
- Primary completion
- 2020-10-23
- Completion
- 2020-10-23
- First posted
- 2020-07-31
- Last updated
- 2022-09-13
Locations
1 site across 1 country: Canada
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04494035. Inclusion in this directory is not an endorsement.